Literature DB >> 16198948

Unenhanced CT and acute stroke physiology.

Thomas Kucinski1.   

Abstract

Unenhanced CT remains the most widely used imaging technique and is the standard of care for acute stroke evaluation. Early ischemic signs (EIS) within the first 3 to 6 hours of symptom onset (eg, parenchymal hypodensity, sulcal effacement, and dense vessel) have been advocated as a triage tool for thrombolytic therapy. Recent studies have challenged the relevance of these EIS within 3 hours of stroke onset, with advanced MR and CT methods increasingly competing with unenhanced CT as the primary imaging modality for acute ischemia. Nonetheless, the insights regarding acute stroke physiology provided by studying the CT evolution of early ischemic signs continue to be valuable for the informed interpretation of all stroke images. It is these insights that comprise the topic of this article.

Entities:  

Mesh:

Year:  2005        PMID: 16198948     DOI: 10.1016/j.nic.2005.06.006

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  4 in total

Review 1.  Imaging in acute stroke--a personal view.

Authors:  Thomas Kucinski
Journal:  Klin Neuroradiol       Date:  2009-05-15

2.  Reversal of CT hypodensity after acute ischemic stroke.

Authors:  Michael Yannes; Jennifer V Frabizzio; Qaisar A Shah
Journal:  J Vasc Interv Neurol       Date:  2013-06

3.  Virtual monoenergetic dual-energy CT reconstructions at 80 keV are optimal non-contrast CT technique for early stroke detection.

Authors:  Doris Dodig; Zrinka Matana Kaštelan; Nina Bartolović; Slaven Jurković; Damir Miletić; Zoran Rumboldt
Journal:  Neuroradiol J       Date:  2021-09-22

4.  Gray-Matter Volume Estimate Score: A Novel Semi-Automatic Method Measuring Early Ischemic Change on CT.

Authors:  Dongbeom Song; Kijeong Lee; Eun Hye Kim; Young Dae Kim; Hye Sun Lee; Jinkwon Kim; Tae-Jin Song; Sung Soo Ahn; Hyo Suk Nam; Ji Hoe Heo
Journal:  J Stroke       Date:  2015-10-15       Impact factor: 6.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.